The Epoch Times
Support Us
The Epoch Times
The Epoch Times
California Takes Controversial Approach to Fentanyl Crisis
Illustration by The Epoch Times, Freepik
Premium Reports

California Takes Controversial Approach to Fentanyl Crisis

California spends billions to stigmatize smoking, while destigmatizing the deadliest drug in U.S. history.
Illustration by The Epoch Times, Freepik
Premium Reports

California Takes Controversial Approach to Fentanyl Crisis

California spends billions to stigmatize smoking, while destigmatizing the deadliest drug in U.S. history.
FacebookXTruthGettrLinkedInTelegramEmail
Add to My List
Save
By Beige Luciano-Adams
|
November 03, 2024Updated:November 18, 2024

By now the statistics are familiar: Fentanyl is killing Americans at an unprecedented rate—around 73,000 annually.

For those aged 18 to 45, it is the leading cause of death.

More Premium Reports
see more
3 Key Supreme Court Cases to Watch in Early 2026

3 Key Supreme Court Cases to Watch in Early 2026

2025 in Review: How Trump Reshaped America and the World

2025 in Review: How Trump Reshaped America and the World

The Global Trend Targeting China’s Weaponized Trade

The Global Trend Targeting China’s Weaponized Trade

In Texas, a 400-Acre Muslim Development Sparks Controversy

In Texas, a 400-Acre Muslim Development Sparks Controversy

Trump Is Global Newsmaker of the Year: Epoch Times Readers’ Choice

Trump Is Global Newsmaker of the Year: Epoch Times Readers’ Choice

Top 8 Senate Races to Watch in 2026

Top 8 Senate Races to Watch in 2026

How the AI Bubble Is Being Masked Within Big Tech

How the AI Bubble Is Being Masked Within Big Tech

Why Trump Is Taking the Fight to Venezuela’s Doorstep

Why Trump Is Taking the Fight to Venezuela’s Doorstep

2025: The Year in Photos

2025: The Year in Photos

How ‘Minnesota Nice,’ Progressive Policies Paved Way for Somali Fraud

How ‘Minnesota Nice,’ Progressive Policies Paved Way for Somali Fraud

AD
Add to My List
Save
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.